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Objective: To investigate the effectiveness and safety of a new single-incision mini-sling (SIMS)d
Ajustdcompared with the standard transobturator midurethral sling (SMUS)dAligndfor the treatment
of female stress urinary incontinence (SUI).
Materials and Methods: A retrospective cohort study was conducted between January 1, 2010 and August
31, 2012. Women with SUI who underwent either SMUS-Align or SIMS-Ajust were recruited. The primary
outcomes included operation time, estimated operative blood loss, postoperative pain, and complica-
tions. The secondary outcomes included subjective and objective success, deﬁned as an International
Consultation on Incontinence Questionnaire (ICIQ) score of 0 or improvement as felt by the patient and a
long-term complication, such as dyspareunia and mesh erosion after 6 months and 12 months of follow-
up.
Results: A total of 136 patients were enrolled, including 76 receiving SMUS-Align and 60 receiving SIMS-
Ajust. Baseline characteristics of the patients in both groups were similar, without a statistically signif-
icant difference. Primary outcomes between both groups were similar, except that women treated with
SIMS-Ajust had statistically signiﬁcantly shorter operation time (p ¼ 0.003), less intent to treat (p < 0.05),
and earlier postoperative discharge (p ¼ 0.001) than women treated with SMUS-Align. Secondary out-
comes were similar without a signiﬁcant difference between the two groups (93% vs. 88% success rate in
each group).
Conclusion: Our results showed that SIMS-Ajust was not inferior to SMUS-Align with respect to success
rate, and might have a slight advantage in early discharge. A long-term follow-up or prospective study is
needed to conﬁrm the above ﬁndings.
Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.epartment of Obstetrics and
ational Yang-Ming University
pei 112, Taiwan.
rng).
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Urinary incontinence (UI), as a worldwide problem, is a dis-
tressing symptom that has a major impact on women's quality of
life, because UI leads to embarrassment, anxiety, and in some cases,
social isolation [1]. UI affects 10e40% of women, with the most
common type known as stress urinary incontinence (SUI) [2]. Risk
factors for SUI include increased number of vaginal deliveries,by Elsevier Taiwan LLC. All rights reserved.
Table 1
Baseline characteristics of women with stress urinary incontinence treated with
SIMS-Ajust or SMUS-Align.
Study group (SIMS)
n ¼ 60
Standard group (SMUS)
n ¼ 76
p
Age (y) 58.5 ± 10.8 59.9 ± 11.2 0.44
Parity 2.7 ± 1.2 2.8 ± 1.7 0.62
BMI (kg/m2) 0.65
> 25 35 (58.3) 46 (62.2)
 25 25 (41.7) 28 (37.8)
Menopause 46 (76.7) 61 (80.3) 0.61
Descriptive statistics are presented as means ± standard deviation or n (%).
BMI ¼ body mass index; SIMS ¼ single-incision mini-sling-Ajust; SMUS ¼ standard
transobturator midurethral sling-Align.
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depression, and stroke [1]. Nearly 50e70% of womenwith SUI seek
medical help; however, these women often delay doing so. One
report showed that the delay in seekingmedical carewas as long as
6e9 years [3]; moreover, of the women who seek help, only 5% of
those who live in the community and 2% of those who live in long-
term care facilities will receive appropriate treatment [3].
Behavioral modiﬁcation as well as physical intervention is the
mainstay of conservative treatment, which is considered as a ﬁrst-
line approach. Lifestyle modiﬁcations include weight loss, smoking
cessation, avoiding caffeine, and prevention of constipation. Phys-
ical interventions include pelvic ﬂoor muscle exercise (Kegel exer-
cises) or biofeedback to strengthen and improve the function and
support of the pelvic ﬂoor muscles, and voiding control practice,
such as bladder training, voiding at a set time, and establishing the
habit of voiding. Medical treatment is often considered as an
alternative. If conservative treatment with/without medical treat-
ment does not provide satisfactory improvement, surgery can be
contemplated.
Since the description of suprapubic cystotomy by Baker-Brown
[4] in 1864, > 160 different surgical procedures (retropubic ure-
thropexy) have been described for the treatment of SUI. There are
two conventional routes used to access the retropubic space: the
transperitoneal and extraperitoneal [5]. Over the past 30 years,
attention has been directed toward developing less-invasive pro-
cedures in place of the originally designed surgery (retropupic
urethropexy). These less-invasive techniques signiﬁcantly reduced
morbidity, hospital stay, and time taken to return to normal ac-
tivities. In addition, along with the invention of mesh, midurethral
sling procedures, including tension-free vaginal tape (TVT) by
Ulmsten et al [6] in 1996 and standard transobturator mid-urethral
slings (SMUSs), such as transobturator vaginal tape inside-out
(TVT-O) by de Leval [7] in 2003, have been rapidly adopted, due
to the simplifying of the Burch procedure and avoiding technical
difﬁculty in laparoscopy. Now, both slings and retropubic ure-
thropexy are considered ﬁrst-line surgical options [8].
SUI after surgery is sometimes associated with adverse events,
including bladder and bowel injury, groin pain and hematoma
formation. This led to the development of minimally invasive and
third-generation single-incision slings, also referred to as single-
incision mini-slings (SIMSs). However, SIMSs are associated with
inferior patient-reported and objective cure rates in short-term
follow-up, and higher reoperation rates for SUI compared with
SMUSs [9,10]. As a result, some SIMSs, for example, the Gynecare
TVT Secure (Gynecare, Ethicon Inc., Somerville, MA, USA), were
withdrawn from the market [11]. However, not enough evidence
has been gathered on other single-incision slings and retropubic or
transobturator slings to allow reliable comparisons [9]. In addition,
nearly all published articles are obtained from Western countries
[9e14]. Finally, no paper comparing the effectiveness of SIMS-Ajust
(C.R. Bard, Murray Hill, NJ, USA) and the SMUS-Align Urethral
Support System (C.R. Bard) in the management of female SUI has
been seen in the literature. The aim of this study was to compare
the efﬁcacy and safety of SIMS using Ajust and SMUS using Align
Urethral Support System (a retropubic midurethral sling) in the
management of women with SUI.
Materials and methods
This was a retrospective cohort study, and followed written
operating procedures, Good Clinical Practice guidelines, and
applicable regulatory requirements. The study was approved by the
Institutional Review Board of Taipei Veterans General Hospital,
Taipei, Taiwan (VGHIRB No.: 2014-08-006CC). The board is orga-
nized under, and operates according to the InternationalConference on Harmonisation (ICH)/World Health Organization
Good Clinical Practice and applicable laws and regulations. All
women who received surgical management of SUI, which was
conﬁrmed by urodynamic study at Taipei Veterans General Hospital
from January 1, 2011 to August 31, 2012 were enrolled in the study.
Womenwho met the following criteria, including loss to follow-up,
history of previous surgery for SUI, pelvic organ prolapse accom-
panied with or without other surgery, such as hysterectomy and/or
other surgery for pelvic organ prolapse, and any additional surgery,
were excluded.
To make this study even more uniform and consistent, the
following criteria had to be met, including the same anesthesia
method, as intravenous general anesthesia with laryngeal mask for
operation, and a single operator (H.C.H.) to ﬁnish both operations:
SIMS-Ajust and SMUS-Align.
Data such as patients' age, body height, body weight, number of
births, menopausal status, estimated blood loss during operation,
operation time, postoperative pain score using visual analog scale
(VAS) scores, and times of postoperative intravenous pain control
treatment were recorded. We also recorded the degree of symptom
relief, and surgery-related complications, such as difﬁculty in
voiding due to obstruction, wound infection, mesh erosion, or he-
matoma, at follow-up at the outpatient clinic until 12 months after
the operation. We used “cure and improvement” as an endpoint to
evaluate surgical success. The cure rate was deﬁned as an Inter-
national Consultation on Incontinence Questionnaire (ICIQ) score of
0, and improvement was recorded as the patient's impression after
12 months of follow-up.
SPSS for Windows version 15.0 (SPSS Inc., Chicago, IL, USA) was
used for statistical analysis. Descriptive statistics were presented as
means ± standard deviation or percentages. Means were compared
by unpaired t test, and proportions were compared by c2 or Fisher's
exact tests, as appropriate. All calculated p values were two-tailed,
and p < 0.05 was considered statistically signiﬁcant.
Results
Of the 338 patients we followed, 136 fulﬁlled the inclusion
criteria. Seventy-six of these 136 patients received SMUS-Align
surgery and 60 underwent SIMS-Ajust surgery. Mean age was
59.9 years and 58.8 years in the SMUS-Align and SIMS-Ajust
groups, respectively, without a signiﬁcant difference (p ¼ 0.44).
Other background characteristics, including mean number of
births, body mass index (BMI), and menopausal status were similar
between the two groups (Table 1).
Estimated blood loss was 53.2 mL and 51.2 mL in the SMUS-
Align and SIMS-Ajust groups, respectively, without a signiﬁcant
difference (p¼ 0.84). Operation time was signiﬁcantly longer in the
SMUS-Align group than SIMS-Ajust group (31.8 minutes vs. 21.8
minutes, p ¼ 0.003), and patients in the SMUS-Align group had a
Table 3
Comparison of intervention effects on aVAS scores in patients treated with anti-
incontinence surgery (SIMS-Ajust or SMUS-Align).
Variables Regression coefﬁcient Standard error t value p
Intercept 5.50 0.13 43.54 < 0.001
SIMS/SMUS 0.15 0.15 0.98 0.326
3 h/30 min 2.49 0.14 17.94 < 0.001
3 d/30 min 4.51 0.14 32.56 < 0.001
Group*3 h 0.17 0.21 0.82 0.415
Group*3 d 0.07 0.21 0.34 0.737
Intent to treat 0.10 0.05 1.99 0.047
SIMS ¼ single-incision mini-sling-Ajust; SMUS ¼ standard transobturator mid-
urethral sling-Align; VAS ¼ visual analog scale.
a VAS ¼ 5.50 þ 0.15*(group)  2.49*(3 h/30 min)  4.51*(3 d/
30 min) þ 0.17*(interaction of 3 h and groups)  0.07*(interaction of 3 d and
groups)  0.10*(intent to treat).
Table 4
Secondary outcome of women treated with SIMS-Ajust or SMUS-Align.
Study group (SIMS)
n ¼ 60
Standard group (SMUS)
n ¼ 76
p
6 mo
Success 57 (95.0) 70 (92.1) 0.421
Cure 50 (83.3) 59 (77.6) 0.374
Improvement 7 (11.6) 11 (14.5) 0.634
1 y
Success 56 (93.3) 67 (88.2) 0.311
Cure 49 (81.7) 56 (73.7) 0.273
Improvement 7 (11.6) 11 (14.5) 0.634
Descriptive statistics are presented as means ± standard deviation or n (%).
Cure ¼ ICIQ-UI Short Form score ¼ 0; ICIQ-UI ¼ International Consultation on In-
continence Questionnaire-Urinary Incontinence; SIMS ¼ single-incision mini-sling-
Ajust; SMUS ¼ standard transobturator midurethral sling-Align; Success rate ¼ 1-
year follow-up with relief of symptoms.
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group, p ¼ 0.001). Surgical complication rate was similar between
the two groups (3.9% in the SMUS-Align group and 5.0% in the
SIMS-Ajust group), including two patients with urinary tract
infection (UTI) in each group. One patient with a SIMS-Ajust was
complicated with hematoma and another with a SMUS-Align had a
urinary tract obstruction, and needed surgery to relieve the slings.
Postoperative residual volume of urine was 57.6 mL in the SMUS-
Align group and 72.1 mL in the SIMS-Ajust group (p ¼ 0.212). Pa-
tients in the SIMS-Ajust group had less frequency of intent to treat
than those in the SMUS-Align group (Table 2).
In both the SMUS-Align and SIMS-Ajust groups, VAS scores were
lower when measured at 3 hours than at 30 minutes post-
operation (p < 0.001), and were also lower when measured at 3
days than at 3 hours post-operation (p < 0.001; Table 3). However,
no signiﬁcant difference in VAS scores between the two groups was
found after each postoperative follow-up (30 minutes, 3 hours, and
3 days; Table 3).
Secondary outcomes were similar in both groups, regardless of
6- or 12-month follow-up. Both surgical procedures showed nearly
90% success rates, and cure rates were > 70% at the end of the 2-
year follow-up (Table 4). Neither dyspareunia nor mesh erosion
was found in either group during the 1-year follow-up.
Discussion
Similar to other countries, increasing use of the midurethral
sling in the management of female SUI was found in Taiwan in a
population-based, nationwide, follow-up descriptive study [15].
However, the effectiveness of SIMS in women with SUI in Taiwan is
still uncertain. Only one study from Taiwan has compared the
clinical outcome of a SIMS-MiniArc (SIS, American Medical Systems
Inc., Minnetonka, MN, USA) and SMUS-Monarc (TOT; American
Medical Systems) in the management of female SUI, and the results
showed a similar mechanism of action with comparable subjective
and objective clinical outcomes [16]. Our current study might be
the ﬁrst comparing two devices from the same company: SIMS-
Ajust and SMUS-Align (C.R. Bard) in the management of female
SUI, based on our limited knowledge and a literature review,
including two recent meta-analyses [14,17], and three previous
studies [12e14]. Schellart and colleagues [12] conducted a 1-year
randomized clinical trial to compare the efﬁcacy and morbidity of
SIMS-MiniArc and SMUS-Monarc and showed that SIMS-MiniArc
was non-inferior to SMUS-Monarc with respect to cure, and was
superior with respect to pain and recovery. By contrast, Madsen
and colleagues [13] found that SIMS-MiniArc was less effective,
with more postoperative incontinence, less patient-reported
improvement and satisfaction, and higher reoperation rates for
SUI, compared with retropubic SMUS-ALIGN. Mostafa and col-
leagues [18] conducted a multicenter prospective randomizedTable 2
Primary outcome of women treated with SIMS-Ajust or SMUS-Align.
Study group (SIMS)
n ¼ 60
Standard group (SMUS)
n ¼ 76
p
EBL (mL) 51.2 ± 48.9 53.2 ± 67.1 0.844
Operation time (min) 21.8 ± 17.7 31.8 ± 19.8 0.003
Intent to treata 0.5 ± 0.3 1.2 ± 1.1 <0.001
PVR 72.1 ± 55.0 57.6 ± 74.8 0.212
Hospitalization (d) 3.7 ± 0.8 4.3 ± 1.2 0.001
Complications 3 (5.0) 3 (3.9) 0.767
Descriptive statistics are presented as means ± standard deviation or n (%).
EBL ¼ estimated blood loss; PVR ¼ post-voiding residual urine; SIMS ¼ single-
incision mini-sling-Ajust; SMUS ¼ standard transobturator midurethral sling-Align.
a Patients requested extra postoperative pain relief.study of SIMS-Ajust and SMUS-TVT-O in themanagement of female
SUI, and showed that SIMS-Ajust was associated with a signiﬁ-
cantly improved postoperative pain proﬁle and earlier return to
work when compared to SMUS-TVT-O, with encouraging results in
patient-reported and objective success rates at 4e6 months of
follow-up. Grigoriadis and colleagues [19], in a 22.3-month (range,
12e36 months) follow-up, found that SMUS-TVT-O and SIMS-Ajust
showed a similar objective cure rate and improvement rate (86% vs.
84.7%, and 5.9% vs. 4.7%, respectively), and concluded that both
SMUS-TVT-O and SIMS-Ajust seemed to be safe and effective for the
treatment of urodynamic SUI. Our current study design used SIMS-
Ajust in place of the SIMS-MiniArc of Madsen et al's [13] study, and
compared it with SMUS-Align in place of the SMUS-TVT-O of
Mostafa et al's [18] study and Grigoriadis et al's [19] study for the
treatment of female SUI. Our results showed that SIMS-Ajust was
non-inferior to SMUS-Align, with respect to 6- and 12-month
success rates and/or improvement rates, suggesting that both de-
vices could provide similar therapeutic effectiveness for women
with SUI.
The value of SIMS in the management of female SUI could be
supported by a recent meta-analysis [14]. Mostafa and colleagues
[14] investigated 26 randomized controlled trials, including 3308
women, comparing SIMS versus SMUS in the surgical management
of SUI, and found no evidence of signiﬁcant differences between
SIMS and SMUS in patient-reported cure rates, with a risk ratio of
0.94 (95% conﬁdence interval, 0.88e1.0) and objective cure rates
with a risk ratio of 0.98 (95% conﬁdence interval, 0.94e1.01) at a
mean follow-up of 18.6 months.
In fact, SIMS fundamentally differs from SMUS because it has a
shorter trajectory of insertion and therefore needs a robust mech-
anism anchoring it to the obturator complex with a strong post-
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an added advantage that allows post-anchorage adjustment of the
sling tension [14]. This polypropylene anchor design has been
shown in independent animal studies assessing its immediate and
delayed extraction forces to be associated with the strongest and
most robust mechanism anchoring it to the obturator complex
[14,20]. Our current study conﬁrmed the security of the use of
SIMS-Ajust in the management of female SUI, compared with
conventional standard transobturator midurethral slings (SMUS-
Align), suggesting that SIMS-Ajust is one of the best choices in the
management of female SUI during at least the 1-year follow-up
period.
The use of SIMS-Ajust in the management of female SUI has
been reported before. Cornu and colleagues [21] conducted a pro-
spective study enrolling 95 patients implantedwith SIMS-Ajust and
showed a success rate of 80% after a mean follow-up of 21 months
(12e32 months); however, there were some postoperative com-
plications, including one case of vaginal hematoma, one case of
acute urine retention, two cases of UTI, one case of mesh erosion,
and two cases of dyspareunia. The study from China found that the
subjective cure rate and objective cure rate of women with SUI
treated by SIMS-Ajust was 82.3% and 91.2% after 1 year follow-up,
respectively, and 3.2% of women had sling exposure [22]. Another
study from Italy showed the subjective and objective cure rates of
81.5% and 83.7%, respectively, in 92 women with SUI treated with
SIMS-Ajust during 2-year follow-up, and one woman had referred
pain in the right leg, three had mesh extrusions, and one had
recurrent UTI [23]. A report from Brazil shows that thigh pain was
signiﬁcantly increased in the SMUS group compared with the SIMS
group (7.1% vs. 0%, p ¼ 0.045) [24]. In our current study, a 5% short-
term complication rate was noted in women treated with SIMS-
Ajust, including one case of vaginal hematoma and two cases of
UTI. Abdel-Fattah and colleagues further indicated the advantages
of SIMS-Ajust in the management of female SUI, reporting that half
of the patients could be offered the procedure under local anes-
thesia, and SIMS-Ajust had an 80% patient-reported success rate at
the 1-year follow-up [25]. In our current study, SIMS-Ajust had a
93% patient-reported success rate at 1 year follow-up, which
showed no signiﬁcant difference from the standard transobturator
midurethral slings, Align (88%). Because SUI is a common and
relatively troublesome disease in agedwomen [26,27], less invasive
with a similar effectiveness is more acceptable, suggesting that the
use of SIMS-Ajust in place of SMUS-Align might be a trend in the
management of women with SUI in the future.
Although there was no signiﬁcant difference between the SIMS-
Ajust and SMUS-Align groups in VAS scores at each of the same
postoperative time points (30 minutes, 3 hours, and 3 days) in our
study, patients in the SIMS-Ajust group did have fewer instances of
intent to treat, suggesting that subjectively, patients in both groups
had similar degrees of pain, as measured by VAS score, but objec-
tively, patients in the SIMS-Ajust group had less pain, as reﬂected
by fewer instances of intent to treat.Conclusion
Our current study showed that SIMS-Ajust was non-inferior to
SMUS-Align with respect to success rate, and might have a slight
advantage in early discharge among women with SUI. More evi-
dence is needed, and will be provided when larger case numbers
and longer follow-up times are available.Conﬂicts of interest
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